These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11854972)

  • 1. Monitoring depression in patients undergoing alpha-interferon and ribavirin therapy for hepatitis C.
    Wright IA
    Gastroenterol Nurs; 2000; 23(6):275-80. PubMed ID: 11854972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
    Vega Palomares R; Planas Vilà R; Durández Lazaro R; Fábregas Puigtió S
    Gastroenterol Hepatol; 2002 Oct; 25(8):483-6. PubMed ID: 12361528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of anxiolytics and antidepressants before and after treatment with interferon-alpha and ribavirin in patients with hepatitis C].
    García-Toro M; Vilella Martorell A; Carral Martínez M; Jimeno Beltrán T; Román Ruiz del Moral Y; Pradas Guerrero C; Gili Planas M; Roca Bennasar M
    Gastroenterol Hepatol; 2011 Apr; 34(4):307-8. PubMed ID: 21376422
    [No Abstract]   [Full Text] [Related]  

  • 4. Anemia during treatment of hepatitis C in HIV-infected patients.
    Lo Re V; Kostman JR
    AIDS Read; 2004 Oct; 14(10):555-7, 562, 565-71. PubMed ID: 15510392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in depressive symptoms and impact on treatment course among hepatitis C patients undergoing interferon-α and ribavirin therapy: a prospective evaluation.
    Chapman J; Oser M; Hockemeyer J; Weitlauf J; Jones S; Cheung R
    Am J Gastroenterol; 2011 Dec; 106(12):2123-32. PubMed ID: 21826113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin.
    Hoofnagle JH; Ghany MG; Kleiner DE; Doo E; Heller T; Promrat K; Ong J; Khokhar F; Soza A; Herion D; Park Y; Everhart JE; Liang TJ
    Hepatology; 2003 Jul; 38(1):66-74. PubMed ID: 12829988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
    Schaefer M; Schmidt F; Folwaczny C; Lorenz R; Martin G; Schindlbeck N; Heldwein W; Soyka M; Grunze H; Koenig A; Loeschke K
    Hepatology; 2003 Feb; 37(2):443-51. PubMed ID: 12540795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C.
    Shakil AO; McGuire B; Crippin J; Teperman L; Demetris AJ; Conjeevaram H; Gish R; Kwo P; Balan V; Wright TL; Brass C; Rakela J
    Hepatology; 2002 Nov; 36(5):1253-8. PubMed ID: 12395337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
    Mousa DH; Abdalla AH; Al-Shoail G; Al-Sulaiman MH; Al-Hawas FA; Al-Khader AA
    Transplant Proc; 2004; 36(6):1831-4. PubMed ID: 15350490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C: new treatment overview.
    Stoia J
    AIDS Treat News; 1998 Sep; (302):5-6. PubMed ID: 11365763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric side effects of HCV therapy and their treatment: focus on IFN alpha-induced depression.
    Hauser P
    Gastroenterol Clin North Am; 2004 Mar; 33(1 Suppl):S35-50. PubMed ID: 15081102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C important treatment advance: interview with Douglas Dieterich, M.D. Interview by John S. James.
    Dieterich D
    AIDS Treat News; 1998 May; (No 295):1-5. PubMed ID: 11365406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of ribavirin mutagenicity in human hepatitis C virus infection.
    Chevaliez S; Brillet R; Lázaro E; Hézode C; Pawlotsky JM
    J Virol; 2007 Jul; 81(14):7732-41. PubMed ID: 17494069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin.
    Yalcin K; Degertekin H; Yildiz F; Kilinc N
    J Gastroenterol; 2003; 38(8):796-800. PubMed ID: 14505137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcoidosis presenting as tattoo changes in a patient undergoing treatment with interferon-alpha and ribavirin.
    Werchniak AE; Cheng SX; Dhar AD; Klaus SN
    Clin Exp Dermatol; 2004 Sep; 29(5):547-8. PubMed ID: 15347347
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C.
    Galvão-de Almeida A; Quarantini LC; Sampaio AS; Lyra AC; Parise CL; Paraná R; de Oliveira IR; Koenen KC; Miranda-Scippa A; Guindalini C
    Brain Behav Immun; 2011 Oct; 25(7):1491-7. PubMed ID: 21693183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus infection in dialysis patients.
    Sułowicz W; Radziszewski A; Chowaniec E
    Hemodial Int; 2007 Jul; 11(3):286-95. PubMed ID: 17576291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy for hepatitis C.
    TreatmentUpdate; 1998 Mar; 10(1):2-3. PubMed ID: 11365430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple fixed drug eruption with interferon/ribavirin combination therapy for hepatitis C virus infection.
    Sidhu-Malik NK; Kaplan AL
    J Drugs Dermatol; 2003 Oct; 2(5):570-3. PubMed ID: 14558408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.